Alerus Financial Na Abbott Laboratories Transaction History

Alerus Financial Na

$1.29 Billion
Q2 2024

A detailed history of Alerus Financial Na transactions in Abbott Laboratories stock. As of the latest transaction made, Alerus Financial Na holds 2,780 shares of ABT stock, worth $320,534. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,780

Previous 2,824 1.56%

Holding current value

$320,534

Previous $320,000 10.0%

% of portfolio

0.02%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$100.73 - $112.44 $4,432 - $4,947	-44 Reduced 1.56%	2,780 $288,000
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $10.4 Million - $12.7 Million	-114,930 Reduced 97.6%	2,824 $310,000
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $10.8 Million - $13 Million	113,149 Added 2457.09%	117,754 $11.4 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $302,340 - $336,870	-3,000 Reduced 39.45%	4,605 $502,000
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $136,572 - $160,754	-1,410 Reduced 15.64%	7,605 $770,000
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $310,370 - $364,112	-3,265 Reduced 26.59%	9,015 $989,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $3.02 Million - $3.49 Million	-31,172 Reduced 71.74%	12,280 $1.19 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $1.72 Million - $2.08 Million	-16,864 Reduced 27.96%	43,452 $4.72 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $23,146 - $28,225	203 Added 0.34%	60,316 $7.14 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $481,297 - $589,322	-4,166 Reduced 6.48%	60,113 $8.46 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $751,757 - $831,662	6,444 Added 11.14%	64,279 $7.59 Million
Q2 2021 Aug 11, 2021	SELL	$105.79 - $124.53 $37,449 - $44,083	-354 Reduced 0.61%	57,835 $6.71 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $244,998 - $288,645	-2,251 Reduced 3.72%	58,189 $6.97 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $153,825 - $167,625	1,465 Added 2.48%	60,440 $6.62 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $1.32 Million - $1.6 Million	-14,379 Reduced 19.6%	58,975 $6.42 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $986,910 - $1.26 Million	12,889 Added 21.32%	73,354 $6.71 Million
Q1 2020 May 12, 2020	BUY	$62.82 - $91.86 $298,143 - $435,967	4,746 Added 8.52%	60,465 $4.77 Million
Q4 2019 Feb 11, 2020	SELL	$78.51 - $87.4 $19,470 - $21,675	-248 Reduced 0.44%	55,719 $4.84 Million
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $337,753 - $366,229	4,127 Added 7.96%	55,967 $4.68 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $88,767 - $103,530	1,218 Added 2.41%	51,840 $4.36 Million
Q1 2019 May 06, 2019	BUY	$66.22 - $80.06 $1.89 Million - $2.29 Million	28,602 Added 129.89%	50,622 $4.05 Million
Q4 2018 Feb 04, 2019	BUY	$65.56 - $74.27 $1.44 Million - $1.64 Million	22,020 New	22,020 $1.59 Million

Others Institutions Holding ABT

# of Institutions

3,181

Shares Held

1.33B

Call Options Held

8.62M

Put Options Held

7.18M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alerus Financial Na, based on Form 13F filings with the SEC.

News

Stay updated on Alerus Financial Na with notifications on news.

Account

Alerus Financial Na Abbott Laboratories Transaction History